KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) Income from Continuing Operations (2017 - 2025)

Cardlytics (CDLX) has disclosed Income from Continuing Operations for 9 consecutive years, with 8250000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 47.08% year-over-year to 8250000.0, compared with a TTM value of 103488000.0 through Dec 2025, up 45.33%, and an annual FY2025 reading of 103488000.0, up 45.33% over the prior year.
  • Income from Continuing Operations was 8250000.0 for Q4 2025 at Cardlytics, up from 72673000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 33038000.0 in Q1 2022 and bottomed at 378279000.0 in Q4 2022.
  • Average Income from Continuing Operations over 5 years is 51066150.0, with a median of 23737000.0 recorded in 2023.
  • Peak annual rise in Income from Continuing Operations hit 232.71% in 2022, while the deepest fall reached 3096.27% in 2022.
  • Year by year, Income from Continuing Operations stood at 11835000.0 in 2021, then crashed by 3096.27% to 378279000.0 in 2022, then soared by 73.34% to 100836000.0 in 2023, then soared by 84.54% to 15589000.0 in 2024, then skyrocketed by 47.08% to 8250000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for CDLX at 8250000.0 in Q4 2025, 72673000.0 in Q3 2025, and 9283000.0 in Q2 2025.